Difficulty: Medium
Average Score: 85%
Practice
Dobutamine:
Correct answer
D
Rationale
In the context of pharmacological lifespan treatment, understanding the properties and effects of medications like dobutamine is crucial for healthcare professionals. In this case, the correct answer is D) predominantly affects D2 receptors in the central nervous system.
Rationale:
- Correct Answer (D): Dobutamine predominantly affects D2 receptors in the central nervous system. While it is primarily known for its beta-1 adrenergic agonist effects, it also acts on dopamine receptors in the brain, specifically D1 and D2 receptors. This dual mechanism of action contributes to its positive inotropic effects.
- Incorrect Answers:
A) has no arrhythmogenic effect: This is incorrect as dobutamine can indeed cause arrhythmias, especially at higher doses due to its beta-1 agonist properties.
B) decreases myocardial oxygen consumption: This is incorrect as dobutamine increases myocardial oxygen consumption due to its positive inotropic effects.
C) is a non-selective ╬▓ agonist: This is incorrect as dobutamine is a selective beta-1 agonist, which differentiates it from non-selective beta agonists like isoproterenol.
Educational Context:
Understanding the pharmacological properties of medications like dobutamine is essential for healthcare professionals to make informed decisions regarding patient care. By knowing that dobutamine predominantly affects D2 receptors in the central nervous system in addition to its beta-1 agonist effects, clinicians can anticipate its therapeutic effects and potential side effects, leading to improved patient outcomes.
Rationale:
- Correct Answer (D): Dobutamine predominantly affects D2 receptors in the central nervous system. While it is primarily known for its beta-1 adrenergic agonist effects, it also acts on dopamine receptors in the brain, specifically D1 and D2 receptors. This dual mechanism of action contributes to its positive inotropic effects.
- Incorrect Answers:
A) has no arrhythmogenic effect: This is incorrect as dobutamine can indeed cause arrhythmias, especially at higher doses due to its beta-1 agonist properties.
B) decreases myocardial oxygen consumption: This is incorrect as dobutamine increases myocardial oxygen consumption due to its positive inotropic effects.
C) is a non-selective ╬▓ agonist: This is incorrect as dobutamine is a selective beta-1 agonist, which differentiates it from non-selective beta agonists like isoproterenol.
Educational Context:
Understanding the pharmacological properties of medications like dobutamine is essential for healthcare professionals to make informed decisions regarding patient care. By knowing that dobutamine predominantly affects D2 receptors in the central nervous system in addition to its beta-1 agonist effects, clinicians can anticipate its therapeutic effects and potential side effects, leading to improved patient outcomes.